Literature DB >> 21880720

2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

Anna-Karin Tidén1, Tove Sjögren, Mats Svensson, Alexandra Bernlind, Revathy Senthilmohan, Francoise Auchère, Henrietta Norman, Per-Olof Markgren, Susanne Gustavsson, Staffan Schmidt, Stefan Lundquist, Louisa V Forbes, Nicholas J Magon, Louise N Paton, Guy N L Jameson, Håkan Eriksson, Anthony J Kettle.   

Abstract

Myeloperoxidase (MPO) is a prime candidate for promoting oxidative stress during inflammation. This abundant enzyme of neutrophils uses hydrogen peroxide to oxidize chloride to highly reactive and toxic chlorine bleach. We have identified 2-thioxanthines as potent mechanism-based inactivators of MPO. Mass spectrometry and x-ray crystal structures revealed that these inhibitors become covalently attached to the heme prosthetic groups of the enzyme. We propose a mechanism whereby 2-thioxanthines are oxidized, and their incipient free radicals react with the heme groups of the enzyme before they can exit the active site. 2-Thioxanthines inhibited MPO in plasma and decreased protein chlorination in a mouse model of peritonitis. They slowed but did not prevent neutrophils from killing bacteria and were poor inhibitors of thyroid peroxidase. Our study shows that MPO is susceptible to the free radicals it generates, and this Achilles' heel of the enzyme can be exploited to block oxidative stress during inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880720      PMCID: PMC3199503          DOI: 10.1074/jbc.M111.266981

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Large-scale purification of myeloperoxidase from HL60 promyelocytic cells: characterization and comparison to human neutrophil myeloperoxidase.

Authors:  H R Hope; E E Remsen; C Lewis; D M Heuvelman; M C Walker; M Jennings; D T Connolly
Journal:  Protein Expr Purif       Date:  2000-04       Impact factor: 1.650

2.  Integration of macromolecular diffraction data.

Authors:  A G Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-10

Review 3.  Biomarkers of myeloperoxidase-derived hypochlorous acid.

Authors:  C C Winterbourn; A J Kettle
Journal:  Free Radic Biol Med       Date:  2000-09-01       Impact factor: 7.376

Review 4.  Living with a killer: the effects of hypochlorous acid on mammalian cells.

Authors:  J M Pullar; M C Vissers; C C Winterbourn
Journal:  IUBMB Life       Date:  2000 Oct-Nov       Impact factor: 3.885

5.  Transient and steady-state kinetics of the oxidation of substituted benzoic acid hydrazides by myeloperoxidase.

Authors:  U Burner; C Obinger; M Paumann; P G Furtmüller; A J Kettle
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

6.  Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis.

Authors:  J P Gaut; G C Yeh; H D Tran; J Byun; J P Henderson; G M Richter; M L Brennan; A J Lusis; A Belaaouaj; R S Hotchkiss; J W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

7.  Redox properties of the couple compound I/native enzyme of myeloperoxidase and eosinophil peroxidase.

Authors:  J Arnhold; P G Furtmüller; G Regelsberger; C Obinger
Journal:  Eur J Biochem       Date:  2001-10

8.  X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution.

Authors:  T J Fiedler; C A Davey; R E Fenna
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

9.  Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation.

Authors:  Renliang Zhang; Marie-Luise Brennan; Zhongzhou Shen; Jennifer C MacPherson; Dave Schmitt; Cheryl E Molenda; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-09-30       Impact factor: 5.157

10.  Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase.

Authors:  Paul Georg Furtmüller; Jürgen Arnhold; Walter Jantschko; Hans Pichler; Christian Obinger
Journal:  Biochem Biophys Res Commun       Date:  2003-02-07       Impact factor: 3.575

View more
  40 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

2.  Myeloperoxidase deficiency attenuates systemic and dietary iron-induced adverse effects.

Authors:  Xia Xiao; Piu Saha; Beng San Yeoh; Jennifer A Hipp; Vishal Singh; Matam Vijay-Kumar
Journal:  J Nutr Biochem       Date:  2018-08-21       Impact factor: 6.048

3.  Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.

Authors:  Marilina Antonelou; Erik Michaëlsson; Rhys D R Evans; Chun Jing Wang; Scott R Henderson; Lucy S K Walker; Robert John Unwin; Alan D Salama
Journal:  J Am Soc Nephrol       Date:  2019-12-26       Impact factor: 10.121

4.  Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.

Authors:  Aaron Roth; Sean Ott; Kelli M Farber; Teresa A Palazzo; Wayne E Conrad; Makhluf J Haddadin; Dean J Tantillo; Carroll E Cross; Jason P Eiserich; Mark J Kurth
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

5.  Inhibition of Myeloperoxidase.

Authors:  Jala Soubhye; Paul G Furtmüller; Francois Dufrasne; Christian Obinger
Journal:  Handb Exp Pharmacol       Date:  2021

6.  Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs.

Authors:  Jiansheng Huang; Forrest Smith; Peter Panizzi
Journal:  Arch Biochem Biophys       Date:  2014-03-13       Impact factor: 4.013

7.  Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease.

Authors:  Joshua D Chandler; Camilla Margaroli; Hamed Horati; Matthew B Kilgore; Mieke Veltman; H Ken Liu; Alexander J Taurone; Limin Peng; Lokesh Guglani; Karan Uppal; Young-Mi Go; Harm A W M Tiddens; Bob J Scholte; Rabindra Tirouvanziam; Dean P Jones; Hettie M Janssens
Journal:  Eur Respir J       Date:  2018-10-10       Impact factor: 16.671

8.  Thioxo-dihydroquinazolin-one Compounds as Novel Inhibitors of Myeloperoxidase.

Authors:  Yang Li; Thota Ganesh; Becky A Diebold; Yerun Zhu; James W McCoy; Susan M E Smith; Aiming Sun; J David Lambeth
Journal:  ACS Med Chem Lett       Date:  2015-08-31       Impact factor: 4.345

9.  Heterogeneity of hypochlorous acid production in individual neutrophil phagosomes revealed by a rhodamine-based probe.

Authors:  Amelia M Albrett; Louisa V Ashby; Nina Dickerhof; Anthony J Kettle; Christine C Winterbourn
Journal:  J Biol Chem       Date:  2018-08-22       Impact factor: 5.157

Review 10.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.